Dr. Jonathan Schwartz

Return to Grants

Institution Name:
Total Awards:
Award Value:

Awards as PI

Program Type Institution Grant Title Award Value
Clinical Trial Stage Projects Rocket Pharmaceuticals, Inc. A Phase 2 Study Evaluating the Efficacy and Safety of IV Administered rAAV9 Vector Containing RP-A501 in Male Patients with Danon Disease $5,808,735